Related Experiment Video
Updated: Jun 22, 2026
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
Specific cytotoxicity of arabinosylguanine toward cultured T lymphoblasts
Abstract:
Purine nucleoside phosphorylase (PNP) deficiency in humans is associated with a severe T cell immunodeficiency. To understand further and exploit this T cell lymphospecificity, we have compared the cytotoxicities and metabolism of deoxyguanosine, the cytotoxic substrate of PNP and of arabinosylguanine, a deoxyguanosine analogue that is resistant to PNP cleavage, in T cell (8402) and B cell (8392) lines in continuous culture established from the same patient. In comparative growth rate experiments the T cells were 2.3-fold and 400-fold more sensitive to growth inhibition by deoxyguanosine and arabinosylguanine, respectively, than were the B cells. Only the T cells, but not the B cells, could phosphorylate in situ deoxyguanosine or arabinosylguanine to the corresponding triphosphate. Both the phosphorylation and cytotoxicity of arabinosylguanine in the T cell line could be prevented by deoxycytidine, which suggests that deoxycytidine-deoxyguanosine kinase initiated the intracellular metabolism and cytotoxicity of this nucleoside analogue. The sensitivity and selectivity of arabinosylguanine toward the T lymphoblastoid cells suggests a rational approach to the design of chemotherapeutic agents that are directed toward T cell malignancies and other T cell disorders.
Insights
Purine nucleoside phosphorylase (PNP) deficiency causes T cell immunodeficiency. Arabinosylguanine selectively targets T cells, showing potential for treating T cell malignancies and disorders.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- Purine nucleoside phosphorylase (PNP) deficiency leads to severe T cell immunodeficiency.
- Understanding T cell lymphospecificity is crucial for targeted therapies.
Purpose of the Study:
- To compare the cytotoxicity and metabolism of deoxyguanosine and arabinosylguanine in T and B cell lines.
- To investigate the potential of arabinosylguanine as a T cell-specific therapeutic agent.
Main Methods:
- Comparative growth rate experiments using T (8402) and B (8392) cell lines.
- Analysis of deoxyguanosine and arabinosylguanine phosphorylation to triphosphate forms.
- Assessment of deoxycytidine's effect on arabinosylguanine metabolism and cytotoxicity.
Main Results:
- T cells exhibited significantly higher sensitivity to deoxyguanosine (2.3-fold) and arabinosylguanine (400-fold) compared to B cells.
- Only T cells could phosphorylate deoxyguanosine and arabinosylguanine to their triphosphate forms.
- Deoxycytidine inhibited arabinosylguanine phosphorylation and cytotoxicity in T cells, indicating deoxycytidine-deoxyguanosine kinase involvement.
Conclusions:
- Arabinosylguanine demonstrates selective toxicity towards T lymphoblastoid cells.
- This selectivity suggests a promising strategy for developing chemotherapeutic agents targeting T cell malignancies and disorders.
